Seignior Pharmaceuticals Private Limited
About Seignior Pharmaceuticals Private Limited
Data last updated:
Seignior Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 18 September 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51397OR2009PTC011160. Its GSTIN is 21AANCS9748R1ZB (Odisha).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sujit Kumar Padhi (Managing Director) and Sujata Padhi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 928/1624 Andei Sahi Bhairapur Jagatpur, Cuttack, Odisha, India – 754200.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.51 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹1,930 (net margin 0.3%) and EBITDA of ₹2,945 (EBITDA margin 0.5%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Seignior Pharmaceuticals Private Limited's registered office is in Cuttack, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 928/1624 Andei Sahi Bhairapur Jagatpur, Cuttack, Odisha, India – 754200
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Seignior Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Seignior Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Seignior Pharmaceuticals Private Limited, buy the company report.
Financials of Seignior Pharmaceuticals Private Limited
FY 2025 filings availableSeignior Pharmaceuticals Private Limited reported revenue of ₹6.51 Lakh (down 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 36% fall in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,945 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,930 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seignior Pharmaceuticals Private Limited, buy the company report.
Board of directors of Seignior Pharmaceuticals Private Limited
Seignior Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujit Kumar Padhi | Managing Director | 18 Sep 2009 | 17 Years 1 Months | Current |
| Sujata Padhi | Director | 18 Sep 2009 | 17 Years 1 Months | Current |
Peer comparison
Seignior Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anthill Pharmaceuticals Private Limited | ₹6.54 Lakh (FY 2018) | Gorakhpur, Uttar Pradesh, India | ||||
| Seignior Pharmaceuticals Private Limitedthis company | ₹6.51 Lakh (FY 2024) | ₹1,930 | 0.3% | -36.0% | Cuttack, Odisha, India | |
| Pradocia Pharmaceuticals Private Limited | ₹6.49 Lakh (FY 2020) | 252.0% | Pune, Maharashtra, India | |||
| Inpra Pharmaceuticals Private Limited | ₹6.49 Lakh (FY 2020) | 147.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Seignior Pharmaceuticals Private Limited, buy the company report.
Auditor
Seignior Pharmaceuticals Private Limited is audited by SATAPATHY&ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATAPATHY&ASSOCIATES | FY 2017 | 324904E |
Shareholding
The shareholding of Seignior Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Seignior Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Seignior Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seignior Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Seignior Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AANCS9748R1ZB | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Seignior Pharmaceuticals Private Limited, buy the company report.
Recent activity
Seignior Pharmaceuticals Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Sujata Padhi was appointed as Director on 18 Sep 2009.
Frequently asked questions
Seignior Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 18 September 2009 (17+ years old) and is registered under CIN U51397OR2009PTC011160.
Seignior Pharmaceuticals has 2 current directors:
- Sujit Kumar Padhi - Managing Director
- Sujata Padhi - Director
The latest financial statements of Seignior Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Seignior Pharmaceuticals is 21AANCS9748R1ZB, registered in Odisha.
The CIN (Corporate Identification Number) of Seignior Pharmaceuticals is U51397OR2009PTC011160. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seignior Pharmaceuticals was incorporated on 18 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Seignior Pharmaceuticals by revenue are Anthill Pharmaceuticals Private Limited, Pradocia Pharmaceuticals Private Limited, Inpra Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sujata Padhi was appointed as Director on 18 Sep 2009. Sujit Kumar Padhi was appointed as Managing Director on 18 Sep 2009.
The registered office of Seignior Pharmaceuticals is at Plot No – 9281624 Andei Sahi Bhairapur Jagatpur, Cuttack, Odisha, India – 754200.
Seignior Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Seignior Pharmaceuticals is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.